Conversations in Healthcare

Conversations in Healthcare

By ClarivateNewsBusiness News
Download on the App Store

Conversations in Healthcare episodes

  • How Healx uses AI to transform rare disease drug discovery
    In this episode of Conversations in Healthcare, Mike Ward speaks with Dr. Tim Guilliams, the co-founder and CEO of Healx. Healx is an artificial intelligence-powered technology company that's dedicated to helping rare disease patients access life improving treatments. Mike and Tim discuss the company’s innovative approach to drug discovery, choosing which rare diseases to target and how patients are shaping their priorities. Learn more in the full episode, which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). 

    See acast.com/privacy for privacy and opt-out information.

    28 min
  • How the pandemic shifted Roche’s priorities and R&D investments
    In this episode of Conversations in Healthcare, Mike Ward speaks with Richard Erwin, general manager and managing director of Roche Products Limited (UK), which was recorded in collaboration with One Nucleus's ON Helix conference (June 2021). Richard shares how the pandemic has shifted Roche’s priorities and why the organization has heavily increased their investment in R&D. Learn more in the full episode. 

    See acast.com/privacy for privacy and opt-out information.

    32 min
  • Optimizing patient-first clinical trials with advanced site intelligence

    In this episode of Conversations in Healthcare, Mike Ward speaks with Oriol Serra, former Head of Site Intelligence and Selection at Pfizer and Simon Andrews, Vice President of RWD Engagements and Innovations at Clarivate about optimizing patient-first clinical trial design and ensuring trial groups align to real-life populations and needs.  

     

    The group discusses the ins and outs to bring clinical trial management in-house, how to modernize trial designs with emerging data and intelligence, overcoming key challenges and advice for other pharma and biotechs looking to go down this path. Learn more in the full episode. 


    See acast.com/privacy for privacy and opt-out information.

    41 min
  • Showing the value of regulatory intelligence in pharma
    In this episode of Conversations in Healthcare, Mike Ward speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca, and Céline Rodier, Senior Health Policy Manager at Clarivate, about strategies and tools to gather and assess regulatory intelligence, as well as KPIs and approaches to demonstrating ROI within your organization. Get actionable takeaways in the full episode.  

    See acast.com/privacy for privacy and opt-out information.

    32 min
  • Overcoming health inequity in the U.S. and the role of telehealth: Ideas and best practices from Cigna, Henry Ford Health System and the eHealth Initiative

    Increased reliance on telehealth services has been one of the most significant care delivery shifts prompted by the COVID-19 pandemic. However, the pandemic has also thrown more light on the challenges of health inequity in the United States, especially among African American and Hispanic communities. We discuss these issues and potential solutions with leaders at the eHealth Initiative, Cigna and Henry Ford Health System. 


    Panelists include:


    • Wanneh Dixon, who is Director of Programs, Strategy & Development at eHealth Initiative 
    • Will M. Lopez, the National Medical Director-Virtual Care and Senior Medical Director-Behavioral Health at Cigna; and 
    • Denise White-Perkins, who is not only the Vice Chair of Academic Affairs, Associate Residency Program Director, Department of Family Medicine, and Director, Healthcare Equity Initiatives, Office of System Diversity Equity and Inclusion at Henry Ford Health System but is also Clinical Associate Professor, at Wayne State University School of Medicine, Department of Family Medicine and Public Health Sciences 

    See acast.com/privacy for privacy and opt-out information.

    37 min
  • Best practices for university - healthcare partnerships: Learnings from the Institute of Cancer Research

    In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Toby Richardson, who is Head of Business Development and Licensing; Deputy Director of Business and Innovation at The Institute of Cancer Research. Mike and Toby discuss how research collaborations between the ICR and biopharma companies help the Institute achieve its mission to make the discoveries that defeat cancer. Learn more in the full episode.



    See acast.com/privacy for privacy and opt-out information.

    28 min
  • Best practices for university – healthcare partnerships: Learnings from Oxford

    In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Dr. Phil Clare, the Deputy Director, Research Services (Knowledge Exchange and Engagement) at the University of Oxford. Mike and Dr. Clare discuss the key role that university research plays in shaping new medicines and technologies, and what that process looks like. Learn more in the full episode.




    See acast.com/privacy for privacy and opt-out information.

    36 min
  • The evolution of the asset-centric approach in biotech venture capital
    In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.

    See acast.com/privacy for privacy and opt-out information.

    48 min
  • Drugs to Watch 2021
    Clarivate market experts break down the opportunities and potential threats for 2021’s Drugs to Watch – the key drugs expected to be blockbusters by 2026.

    See acast.com/privacy for privacy and opt-out information.

    24 min
  • A novel approach to treating neurodegenerative disease
    In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira’s recent IPO following a successful series B funding round, all during the pandemic. 

    See acast.com/privacy for privacy and opt-out information.

    27 min

About Conversations in Healthcare

From the publisher's feed

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the…